Healthpeak Properties (NYSE:DOC – Get Free Report) had its price objective lowered by equities research analysts at Mizuho from $24.00 to $23.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Mizuho‘s target price would suggest a potential upside of 16.49% from the company’s previous close.
A number of other brokerages have also weighed in on DOC. Wells Fargo & Company raised their price objective on Healthpeak Properties from $19.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday. Royal Bank Of Canada increased their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Citigroup lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. UBS Group upped their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday, November 11th. Finally, Jefferies Financial Group initiated coverage on shares of Healthpeak Properties in a research report on Tuesday, September 15th. They set a “hold” rating and a $21.00 price target on the stock. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $21.60.
Read Our Latest Stock Analysis on DOC
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.41). The firm had revenue of $820.89 million for the quarter, compared to analyst estimates of $739.18 million. Healthpeak Properties had a net margin of 12.32% and a return on equity of 4.04%. Healthpeak Properties’s revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.46 EPS. Equities research analysts forecast that Healthpeak Properties will post 1.77 earnings per share for the current fiscal year.
Insider Buying and Selling at Healthpeak Properties
In other news, EVP Ankit Patadia sold 6,115 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $20.78, for a total transaction of $127,069.70. Following the completion of the sale, the executive vice president owned 2,838 shares in the company, valued at approximately $58,973.64. The trade was a 68.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.23% of the company’s stock.
Institutional Investors Weigh In On Healthpeak Properties
Institutional investors and hedge funds have recently made changes to their positions in the business. State Street Corp increased its position in shares of Healthpeak Properties by 92.3% during the second quarter. State Street Corp now owns 93,267,685 shares of the real estate investment trust’s stock valued at $1,995,928,000 after purchasing an additional 44,767,085 shares during the period. Bank of America Corp DE boosted its position in Healthpeak Properties by 27.5% in the 1st quarter. Bank of America Corp DE now owns 11,887,795 shares of the real estate investment trust’s stock valued at $195,316,000 after buying an additional 2,563,407 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Healthpeak Properties by 2.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 10,583,736 shares of the real estate investment trust’s stock valued at $173,896,000 after purchasing an additional 290,589 shares during the period. Envestnet Asset Management Inc. raised its holdings in Healthpeak Properties by 83.4% in the second quarter. Envestnet Asset Management Inc. now owns 7,761,469 shares of the real estate investment trust’s stock worth $166,095,000 after purchasing an additional 3,530,429 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Healthpeak Properties by 20,832.8% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,217,474 shares of the real estate investment trust’s stock valued at $133,054,000 after purchasing an additional 6,187,772 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.
About Healthpeak Properties
Healthpeak Properties, Inc. is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities. The company’s properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
